Structural Modeling of TRPA1 Ion Channel-Determination of the Binding Site for Antagonists.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
11 May 2022
Historique:
received: 11 04 2022
revised: 06 05 2022
accepted: 09 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 1 6 2022
Statut: epublish

Résumé

TRPA1 is a transmembrane cation channel, one of the most promising targets in the context of respiratory diseases. Its general structure has already been experimentally resolved, but the binding site of TRPA1 antagonists such as HC-030031, a model methylxanthine derivative, remains unknown. The present study aimed to determine the potential binding site of xanthine antagonists and to describe their binding mode, using a molecular modeling approach. This study represents the first attempt to bring together site-directed mutagenesis reports and the latest cryo-EM structure of an antagonist bound to TRPA1. Our research suggests that the core moiety of HC-030031 binds to a pocket formed by the TRP-like domain and the pre-S1, S4, S5 helices of one subunit. The structure, determined by cryo-EM, shows interactions of a core hypoxanthine moiety in the same area of the binding site, sharing the interaction of xanthine/hypoxanthine with Trp-711. Moreover, the predicted binding mode of HC-030031 assumes interaction with Asn-855, a residue demonstrated to be important for HC-030031 recognition in site-directed mutagenesis studies. Our model proved to be advantageous in a retrospective virtual screening benchmark; therefore, it will be useful in research on new TRPA1 antagonists among xanthine derivatives and their bioisosteres.

Identifiants

pubmed: 35630553
pii: molecules27103077
doi: 10.3390/molecules27103077
pmc: PMC9145427
pii:
doi:

Substances chimiques

Calcium Channels 0
Hypoxanthines 0
TRPA1 Cation Channel 0
Xanthines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Science Center
ID : 2020/37/N/NZ7/02365
Organisme : Jagiellonian University
ID : N42/DBS/000187

Références

J Chem Inf Model. 2009 Feb;49(2):377-89
pubmed: 19434839
Nature. 2015 Apr 23;520(7548):511-7
pubmed: 25855297
Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):12301-12306
pubmed: 30429323
Bioinformatics. 2011 Aug 1;27(15):2083-8
pubmed: 21636590
Sci Rep. 2016 Nov 22;6:37460
pubmed: 27874100
Naunyn Schmiedebergs Arch Pharmacol. 2015 Apr;388(4):451-63
pubmed: 25640188
Sci Rep. 2018 Nov 20;8(1):17104
pubmed: 30459425
OMICS. 2009 Aug;13(4):325-30
pubmed: 19645590
Int J Mol Sci. 2020 Sep 11;21(18):
pubmed: 32933054
J Chem Inf Model. 2010 Dec 27;50(12):2191-200
pubmed: 20828173
Nucleic Acids Res. 2012 Jan;40(Database issue):D370-6
pubmed: 21890895
J Med Chem. 2001 Feb 15;44(4):502-11
pubmed: 11170640
Neuron. 2020 Mar 4;105(5):882-894.e5
pubmed: 31866091
Nature. 2020 Sep;585(7823):141-145
pubmed: 32641835
Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):E1184-91
pubmed: 21930928
Nat Rev Drug Discov. 2011 Aug 01;10(8):601-20
pubmed: 21804597
J Exp Med. 2021 Apr 5;218(4):
pubmed: 33620419
J Med Chem. 2012 Jul 26;55(14):6582-94
pubmed: 22716043
J Biol Chem. 2012 Aug 17;287(34):28291-306
pubmed: 22740698
J Med Chem. 2021 Apr 8;64(7):3843-3869
pubmed: 33749283
Nucleic Acids Res. 2018 Jul 2;46(W1):W363-W367
pubmed: 29860391
Biochemistry (Mosc). 2019 Feb;84(2):101-118
pubmed: 31216970
Biophys J. 2013 Feb 19;104(4):798-806
pubmed: 23442958
Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):3762-3767
pubmed: 28320952
Neuron. 2021 Jan 20;109(2):273-284.e4
pubmed: 33152265
PLoS One. 2016 Nov 8;11(11):e0166167
pubmed: 27824920
Nat Neurosci. 2011 May;14(5):595-602
pubmed: 21460831
J Chem Inf Model. 2007 Mar-Apr;47(2):488-508
pubmed: 17288412
Proc Natl Acad Sci U S A. 2019 Dec 17;116(51):26008-26019
pubmed: 31796582
Bioinformatics. 2017 Oct 01;33(19):3036-3042
pubmed: 28575181
Pharm Pat Anal. 2015;4(2):75-94
pubmed: 25853468

Auteurs

Alicja Gawalska (A)

Department of Medicinal Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 30-688 Cracow, Poland.

Marcin Kołaczkowski (M)

Department of Medicinal Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 30-688 Cracow, Poland.

Adam Bucki (A)

Department of Medicinal Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 30-688 Cracow, Poland.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Immune Checkpoint Inhibitors Lung Neoplasms Prognosis Inflammation
Humans Arthroplasty, Replacement, Hip Male Female Obesity, Morbid

Classifications MeSH